Literature DB >> 3968450

Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.

R I Glass, A M Svennerholm, M R Khan, S Huda, M I Huq, J Holmgren.   

Abstract

In rural Bangladesh, family contacts of patients with cholera were studied prospectively to examine whether protection against colonization and disease due to Vibrio cholerae O1 was associated with circulating antibodies to V. cholerae. Family contacts (1,071) of 370 patients with cholera were visited daily for 10 days, cultured for V. cholerae, and queried about diarrhea. Sera collected on days 1 and 21 were assayed for vibriocidal antibodies, IgG and IgA antibodies to cholera toxin, and IgG antibodies to lipopolysaccharide (LPS). Vibriocidal titers of greater than or equal to 20 present in 50% of contacts by 20 years of age were associated with protection against both colonization and disease. An elevated level of IgG antitoxin was not associated with protection against colonization or disease but was the most sensitive indicator of recent symptomatic cholera and of immune response to the oral immunogen B subunit. IgG antibody to LPS and IgA antitoxin were of little value in predicting colonization or disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968450     DOI: 10.1093/infdis/151.2.236

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  85 in total

1.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

2.  Risk Factors for Household Transmission of Vibrio cholerae in Dhaka, Bangladesh (CHoBI7 Trial).

Authors:  Vanessa Burrowes; Jamie Perin; Shirajum Monira; David A Sack; Mahamud-Ur Rashid; Toslim Mahamud; Zillur Rahman; Munshi Mustafiz; Sazzadul I Bhuyian; Farzana Begum; Fatema Zohura; Shwapon Biswas; Tahmina Parvin; Tasdik Hasan; Xiaotong Zhang; Bradley R Sack; K M Saif-Ur-Rahman; Munirul Alam; Christine Marie George
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

3.  Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.

Authors:  Wilbur H Chen; Richard N Greenberg; Marcela F Pasetti; Sofie Livio; Michael Lock; Marc Gurwith; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

4.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

5.  Immunogenicity in Peruvian volunteers of a booster dose of oral cholera vaccine consisting of whole cells plus recombinant B subunit.

Authors:  R E Begue; G Castellares; C Cabezas; J L Sanchez; R Meza; D M Watts; D N Taylor
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  An overview of VaxchoraTM, a live attenuated oral cholera vaccine.

Authors:  Tarun Saluja; Vijayalaxmi V Mogasale; Jean-Louis Excler; Jerome H Kim; Vittal Mogasale
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

7.  Observed Handwashing with Soap Practices Among Cholera Patients and Accompanying Household Members in a Hospital Setting (CHoBI7 Trial).

Authors:  Fatema Zohura; Sazzadul Islam Bhuyian; Shirajum Monira; Farzana Begum; Shwapon K Biswas; Tahmina Parvin; David Sack; R Bradley Sack; Elli Leontsini; K M Saif-Ur-Rahman; Mahamud-Ur Rashid; Rumana Sharmin; Xiaotong Zhang; Munirul Alam; Christine Marie George
Journal:  Am J Trop Med Hyg       Date:  2016-10-03       Impact factor: 2.345

8.  Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.

Authors:  G B Pier; G Meluleni; J B Goldberg
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  Cholera in pregnancy: Clinical and immunological aspects.

Authors:  Ashraful I Khan; Fahima Chowdhury; Daniel T Leung; Regina C Larocque; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Int J Infect Dis       Date:  2015-08-14       Impact factor: 3.623

10.  Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh.

Authors:  Jason B Harris; Michael J Podolsky; Taufiqur R Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Tanya Logvinenko; Jennifer Kendall; Abu S G Faruque; Cathryn R Nagler; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  PLoS Negl Trop Dis       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.